Aortic Stent Graft Market Report and Forecast 2024-2032

The global aortic stent graft market size was valued at USD 3.1 billion in 2023. It is expected to grow at a CAGR of 5.80% during the forecast period of 2024-2032, driven by increasing preference for minimally invasive procedures across the globe. The market is experiencing robust growth and is expected to reach USD 5.2 billion by 2032.

Global Aortic Stent Graft Market Analysis

Aortic stent grafts are medical devices used to reinforce and support weakened sections of the aorta, such as in the case of an abdominal aortic aneurysm (AAA) or thoracic aortic aneurysm (TAA). The market for these devices is expanding due to the growing incidence of aortic aneurysms and the need for effective treatment options.

Market Drivers

• Increasing Prevalence of Aortic Aneurysms: The rising incidence of AAA and TAA is a primary driver for the demand for aortic stent grafts.
• Technological Advancements: Innovations in stent graft design and materials are enhancing their effectiveness and durability.
• Rising Demand for Minimally Invasive Procedures: The preference for less invasive endovascular procedures over traditional open surgeries is fueling market growth.
• Aging Population: The growing elderly population, which is more susceptible to aortic aneurysms, is further driving the demand for stent grafts.

Market Restraints

• High Cost of Devices and Procedures: The elevated price of aortic stent grafts and associated procedures can limit their accessibility, particularly in low- and middle-income countries.
• Risk of Complications: The potential risks and complications associated with stent graft placement, such as endoleaks and migration, can impact market growth.

Market Opportunities

• Emerging Markets: Expanding healthcare infrastructure and increasing awareness in emerging economies present significant growth opportunities.
• Advancements in Imaging Technologies: Improvements in imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), are enhancing the precision of stent graft placement.

Market Challenges

• Regulatory Hurdles: Stringent regulatory requirements for the approval of medical devices can delay the introduction of new stent grafts to the market.
• Reimbursement Issues: Variability in reimbursement policies across different regions can impact the adoption of aortic stent grafts.

Global Aortic Stent Graft Market Outlook

The global aortic stent graft market is expected to grow at a significant CAGR during the forecast period. The market's growth prospects are promising due to the ongoing advancements in stent graft technologies and the increasing preference for minimally invasive treatments.

The global aortic stent graft market is poised for significant growth, driven by the rising burden of aortic aneurysms and technological innovations in stent graft design. The market presents opportunities for companies to innovate and expand their product offerings to meet the evolving needs of patients and healthcare providers.

Global Aortic Stent Graft Market Trends

The global aortic stent graft market is witnessing significant growth, driven by advancements in medical technology, an aging population, and an increasing prevalence of aortic aneurysms. This market is characterized by several key trends that are shaping its current landscape and future outlook.

• Technological Advancements

There has been a substantial focus on the development of more durable, flexible, and compatible stent grafts, enhancing the effectiveness of treatments for abdominal and thoracic aortic aneurysms. Innovations such as fenestrated and branched stent grafts allow for customized treatments of complex aneurysms, improving patient outcomes.

• Minimally Invasive Procedures

The shift towards minimally invasive surgical procedures has significantly impacted the aortic stent graft market. Endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) procedures are preferred over open surgery due to their benefits of reduced recovery times, lower risk of complications, and shorter hospital stays. This trend is encouraging the adoption of aortic stent grafts.

• Rising Incidence of Aortic Aneurysms

The aging global population and lifestyle-related risk factors such as hypertension, smoking, and high cholesterol levels are contributing to an increased incidence of aortic aneurysms. This growing patient pool is driving the demand for aortic stent grafts.

• Regulatory and Reimbursement Challenges

The market's growth is also influenced by regulatory and reimbursement landscapes, which vary significantly across different regions. Manufacturers face stringent regulatory requirements for the approval of new and innovative stent grafts. At the same time, favorable reimbursement policies can enhance the accessibility and affordability of these treatments, thus driving market growth.

• Market Expansion in Emerging Economies

Emerging economies present significant growth opportunities for the aortic stent graft market due to improving healthcare infrastructure, increasing healthcare spending, and rising awareness of aortic aneurysm treatments. Manufacturers are focusing on expanding their presence in these markets to capitalize on their growth potential.

In conclusion, the global aortic stent graft market is poised for continued growth, driven by technological innovations, the preference for minimally invasive procedures, and the increasing prevalence of aortic aneurysms. However, market players must navigate the challenges of regulatory approvals and develop strategies to tap into the potential of emerging markets to maintain and enhance their market positions.

Global Aortic Stent Graft Market Segmentation

Market Breakup by Product

• Abdominal Aortic Stent Graft
• Thoracic Aortic Stent Graft

The global aortic stent graft market is segmented into abdominal aortic stent grafts and thoracic aortic stent grafts, each addressing different areas of the aorta with specific clinical needs. Abdominal aortic stent grafts, catering to abdominal aortic aneurysms, dominate the market due to the higher prevalence of these conditions. This segment benefits from continuous technological advancements and the shift towards minimally invasive procedures, driving its growth. Thoracic aortic stent grafts, used for thoracic aortic aneurysms, though smaller in market size, are experiencing rapid growth due to rising awareness and improvements in diagnostic techniques. Both segments are crucial for the market's expansion, with innovations and an aging population propelling their future growth, positioning them as key drivers in the aortic stent graft market's overall development during the forecast period.

Market Breakup by End User

• Hospitals
• Ambulatory Surgical Centers
• Others

The aortic stent graft market is segmented by end users into hospitals, ambulatory surgical centers (ASCs), and others. Hospitals dominate due to their advanced facilities and ability to handle complex surgeries, driven by rising aortic aneurysm treatments. ASCs are growing rapidly, favored for their efficiency in minimally invasive procedures, cost-effectiveness, and quick recovery benefits. The "others" category, including clinics and outpatient centers, supports the market with services for pre and post-operative care. This segmentation reflects the market's evolution towards patient-centric and cost-effective treatment options, with hospitals leading and ASCs emerging as significant contributors to market growth.

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The global aortic stent graft market exhibits distinct regional dynamics, with North America leading due to advanced healthcare infrastructure, high procedural volumes, and significant investments in R&D. Europe follows, driven by increasing awareness, favorable reimbursement policies, and a strong focus on minimally invasive surgeries. The Asia Pacific region is poised for the fastest growth, attributed to rising healthcare expenditures, an aging population, and improving medical facilities. Latin America and the Middle East and Africa are emerging markets, experiencing gradual growth due to expanding healthcare access and increasing awareness of aortic diseases. Each region's growth is shaped by specific healthcare policies, economic conditions, and demographic trends, contributing to the global expansion of the aortic stent graft market.

Global Aortic Stent Graft Market Competitive Landscape

The competitive landscape of the global aortic stent graft market is marked by the presence of established players and emerging enterprises, contributing to a dynamic and innovative market environment. Leading companies include Cook Group Incorporated, W. L. Gore & Associates, Inc., Medtronic, Terumo Corporation, Cordis, Artivion, Inc., Endologix LLC, Lombard Medical, SB-KAWASUMI LABORATORIES, INC., Endospan, LifeTech Scientific Corporation, Shanghai MicroPort Medical (Group) Co. Ltd., Cardinal Health, and Becton, Dickinson and Company.

Key Questions Answered in the Report

• What is the current and future performance of the global aortic stent graft market?
• What are the key drivers and challenges in the aortic stent graft market?
• What are the significant trends and challenges shaping the global aortic stent graft market?
• How is the global aortic stent graft market segmented on the basis of products, and what drives the growth of these segments?
• What is the market breakup based on end users?
• How do regional dynamics affect the global aortic stent graft market?
• What factors contribute to North America leading the global aortic stent graft market?
• What are the main players/companies in the market?

Key Benefits for Stakeholders

• The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global aortic stent graft market from 2017-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global aortic stent graft market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global aortic stent graft industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

This product will be delivered within 5-7 business days.